Mintz represented ArriVent Biopharma, Inc. on the deal. ArriVent Biopharma, Inc, a Pennsylvania-based company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, announced its $155...
ArriVent Biopharma’s $155M Series B Financing
Vicarious Surgical’s $1.1 Billion SPAC Merger with D8 Holdings Corp.
Mintz advised Vicarious Surgical Inc. on the deal. Vicarious Surgical Inc., a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures...